Pure Appl. Chem., 2003, Vol. 75, No. 11-12, pp. 2549-2553
http://dx.doi.org/10.1351/pac200375112549
Risk management options for endocrine disruptors in national and international programs
Individual author index pages
- J. C. Lamb, IV
- H. B. W. M. Koëter
- R. Becker
- A. Gies
- Les Davies
- T. Inoue
- A. Jacobs
- G. Lyons
- M. Matsumoto
- G. Timm
Other PAC articles by these authors
Advancing the testing and assessment of chemical substances for endocrine disruption: OECD activities
Relevant activities for risk management of endocrine disruptors in Japanese government agencies
Endocrine disruption and the USFDA's Center for Drug Evaluation and Research
Endocrine active substances and the need to improve environmental protection: An environmentalist's perspective
Risk perception: A chemical industry view of endocrine disruption in wildlife
Government view of endocrine disruption in wildlife
Hormonally active agents and plausible relationships to adverse effects on human health